Bluebird Bio reported $239.8M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.95B 667M Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Moderna USD 99.14B 22.26B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 169.88B 6.47B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vertex Pharmaceuticals USD 142.88B 10.37B Nov/2026